Weekly Recap | DUALITYBIO-B -1.92%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:48 AM09606-2.31%
Weekly Recap | DUALITYBIO-B -0.29%, consensus target above spotWeekly Review·Nov 7, 2026 at 06:33 AM09606-2.31%
DUALITYBIO-B Spends Over HKD17M on Buyback of 158,000 Shares on WedAASTOCKS News·Oct 29, 2026 at 02:08 AM09606-2.31%
Chinese drug sector’s stature grows at major cancer conferenceSCMP·Oct 28, 2026 at 01:41 PM03692-2.15%09606-2.31%
BioNTech (BNTX) Hits Key Breast Cancer Trial Goal As Oncology Updates BuildSimplywall·Oct 28, 2026 at 01:03 PMBNTX-0.97%GILD-0.45%